← Open Payments lookup

DEBORAH DRUMM: Open Payments

NPI 1720192297 · NEWTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,031 in 54 payments from 11 companies in 2025. Trend: 2023 $1,188 · 2024 $1,570 · 2025 $1,031

Food & beverage: $1,031
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.5$234
ABBVIE INC.20$187
E.R. Squibb & Sons, L.L.C.2$140
Neurocrine BioSciences, Inc.6$111
Lundbeck LLC5$92
Alkermes, Inc.4$71
Axsome Therapeutics, Inc.4$62
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$59
Teva Pharmaceuticals USA, Inc.2$36
Supernus Pharmaceuticals, Inc.1$22

Products named: REXULTI, VRAYLAR, COBENFY, INGREZZA, ARISTADA, ABILIFY MAINTENA, CAPLYTA, Sunosi.

Industry payments across NJ — which companies pay providers there.